Atara Biotherapeutics Stock Forecast

Buy or Hold candidate since Nov 07, 2025 Gain 15.33%

The Atara Biotherapeutics, Inc. stock price fell by -0.672% on the last day (Monday, 17th Nov 2025) from $13.40 to $13.31. During the last trading day the stock fluctuated 5.77% from a day low at $13.00 to a day high of $13.75. The price has risen in 6 of the last 10 days but is still down by -6.31% for this period. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 4 thousand shares were bought and sold for approximately $54.70 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.12% during the next 3 months and, with a 90% probability hold a price between $12.90 and $19.64 at the end of this 3-month period.

0HIY.L Signals & Forecast

There are mixed signals in the stock today. The Atara Biotherapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.10. On a fall, the stock will find some support from the short-term average at $12.57. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Atara Biotherapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, November 05, 2025, and so far it has risen 20.53%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Atara Biotherapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.16 and $12.03. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Atara Biotherapeutics, Inc. finds support just below today's level at $12.16. If this is broken, then the next support from accumulated volume will be at $12.03 and $11.99.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.750 between high and low, or 5.77%. For the last week, the stock has had daily average volatility of 6.02%.

Our recommended stop-loss: $12.87 (-3.28%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (0HIY.L) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Atara Biotherapeutics, Inc. to open at $13.35, and during the day (based on 14 day Average True Range), to move between $12.82 and $13.80, which gives a possible trading interval of +/-$0.98 (+/-7.64%) up or down from last closing price. If Atara Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.95 (4.81%) than the support at $12.16 (8.60%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Atara Biotherapeutics, Inc. stock A Buy?

Atara Biotherapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.795 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $13.35 ( 0.326%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk